
via AI.Nony.Mous
Finding could revolutionise how all vaccines could be made to be longer lasting
The SARS-Cov-2 pandemic illustrates how variable vaccines can be in their length of efficacy, with regular boosters needed to keep people protected. In comparison, the immunity generated by a single vaccination against the measles virus can last decades.
It has always remained a scientific mystery as to why only some vaccines lead to life-long protection. Now a paper published in the journal, Immunity, led by Prof. David Tarlinton and Dr Marcus Robinson, both from Monash University’s Central Clinical School in Melbourne, Australia, has found that the clue likely lies in the body producing a unique subtype of an immune cell in response to some but not other vaccinations. The finding could revolutionise how all vaccines could be made to be longer lasting.
Vaccines trick our immune cells into thinking the body has been infected. In response, we produce antibodies to fight off what is perceived as an infection. According to Dr Robinson, “most vaccines work by generating high levels of antibodies against these invaders, but how long these antibodies persist in the body is highly variable by vaccine,” he said. “Now we know that the clue is in whether vaccines generate a special subtype of immune cell that produces antibody for long times to fight off infection indefinitely.”
Using an animal model, the researchers studied the lifespan of antibody-secreting cells, identifying surface markers on these cells that indicated longevity. The scientists used a method called ‘timestamping’, which effectively tracks individual antibody-secreting cells across their entire lifespan. “We found those cells with particular markers on them were more likely to be long lasting. They also expressed really distinct patterns of genes, so we think longevity is programmed into the cell.” Dr Robinson said.
“It is these cells we need to target when developing vaccines we want to provide long-lasting protection.”
Importantly the researchers also found that there is a maximum number of these long-lasting antibody-secreting cells the body can hold at any one time, and they generally reside in special sites in tissues like the bone marrow – so improved vaccines will need to focus on maintaining these reservoirs of long acting cells, according to Dr Robinson.
Original Article: Making vaccines longer lasting
More from: Monash University
The Latest Updates from Bing News
Go deeper with Bing News on:
Long lasting vaccines
- Legal Settlement Exonerates Sailors Kicked Out Over COVID-19 Vaccine
A legal settlement protects the careers of 4,300 sailors who refused to take a COVID-19 vaccine for religious reasons.
- GSK cuts vaccine sales outlook after RSV surprise, but CEO puts on bold front on peak potential
The whole RSV vaccine field took a beating when the CDC’s immunization committee doled out a limited recommendation last month. And it’s showing in GSK’s forecast for 2024. | The whole RSV vaccine ...
- GSK’s Weak Vaccine Sales Eclipse Brighter Annual Forecast
GSK Plc shares fell as weakness in its vaccines business overshadowed the British drugmaker’s raised profit forecast for the year. The shares dropped as much as 3% in London as investors fretted over ...
- Navy SEAL COVID-19 vaccine suit settlement vindicates religious objectors
Navy sailors who faced disciplinary actions related to their refusal to comply with the COVID-19 vaccine mandate on account of religion can correct their service records and protect their careers as ...
- Merck Falls as HPV Vaccine Miss Overshadows Profit, Sales Beat
Merck & Co.’s shares fell the most in three years as light sales of its Gardasil HPV vaccine in China dimmed quarterly profit and sales that beat Wall Street estimates.
Go deeper with Bing News on:
Life-long protection vaccines
- COVID-19 vaccines: Get the facts
As the coronavirus disease 2019 (COVID-19) continues to cause illness, you might have questions about COVID-19 vaccines. Find out about the different types of COVID-19 vaccines, how they work, the ...
- Dengue Vaccine Development: Challenges and Emerging Opportunities
the vaccine should provide life-long protection to all four serotype of dengue virus, thus a potential vaccine must be tetravalent; second, the cost of vaccine should be lower and affordable for ...
- Route to more effective malaria vaccines revealed through human-challenge trials
Infecting volunteers with malaria reveals why some get sick and others don't—and points to ways to induce stronger immunity through vaccination.
- Shingles Vaccine Could Lead to Delay in Dementia
The newest shingles vaccine may reduce the risk of dementia better than the older version. Researchers found that Shingrix increased the length of time without shingles by nearly 20%.
- Shingles: New Vaccine, Enhanced Protection
This condition has seriously interfered with her quality of life in her senior years ... we can achieve in preventing diseases that have long plagued humanity. This new vaccine not only promises ...